Inhibition of the Type III Secretion System of Salmonella Enterica Serovar Typhimurium and Alleviation Pathogenicity Via Treatment with Xanthotoxol
Current Microbiology · 2026
DOI: 10.1007/s00284-025-04592-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2026. Verfasst von Xiuli Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: Salmonella typhimurium, Type III Secretion Systems, Anti-Bacterial Agents, Salmonella Infections. Die Arbeit nennt 17 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Antibiotic resistance among bacterial pathogens increasingly undermines the efficacy of conventional therapies, creating an urgent need for alternative strategies that disarm pathogens without imposing strong selective pressure. The Type III secretion system (T3SS) of Salmonella is a syringe‑like protein injection apparatus that translocates bacterial effector proteins into host cells and is essential for epithelial invasion and early stages of pathogenesis. Here, we report that the natural furanocoumarin Xanthotoxol (Xan) inhibits SPI‑1 T3SS function in Salmonella enterica serovar Typhimurium (S. Typhimurium) and protects against infection in vitro and in vivo. Mechanistically, we found that Xan downregulates transcription of key SPI‑1 regulatory genes (hilD, hilC, rtsA and hilA), reduces expression and secretion of SPI‑1 effectors (SipA, SipB, SipC), and blocks effector translocation into host cells. Functionally, Xan selectively reduced S. Typhimurium invasion of epithelial cells without affecting bacterial growth or adhesion. In a streptomycin‑pretreated murine enteritis model, oral Xan treatment decreased bacterial loads in liver and spleen, reduced pro‑inflammatory cytokine levels (TNF‑α, IL‑1β, IL‑6) in cecal homogenates, and ameliorated intestinal and systemic histopathology. Together, these results indicate that Xan is an effective T3SS inhibitor and a promising anti‑virulence candidate that may complement or reduce reliance on traditional antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Lv, H., Li, S., Wang, J., Liu, H., Qiu, J., & Deng, Y. (2026). Inhibition of the Type III Secretion System of Salmonella Enterica Serovar Typhimurium and Alleviation Pathogenicity Via Treatment with Xanthotoxol. Current Microbiology. https://doi.org/10.1007/s00284-025-04592-5
Vancouver
Zhang X, Lv H, Li S, Wang J, Liu H, Qiu J, et al. Inhibition of the Type III Secretion System of Salmonella Enterica Serovar Typhimurium and Alleviation Pathogenicity Via Treatment with Xanthotoxol. Current Microbiology. 2026. doi:10.1007/s00284-025-04592-5
BibTeX
@article{Zhang2026,
author = {Zhang, Xiuli and Lv, Hongfa and Li, Shufang and Wang, Jianfeng and Liu, Hongtao and Qiu, Jiazhang and Deng, Yanhong},
title = {Inhibition of the Type III Secretion System of Salmonella Enterica Serovar Typhimurium and Alleviation Pathogenicity Via Treatment with Xanthotoxol},
journal = {Current Microbiology},
year = {2026},
doi = {10.1007/s00284-025-04592-5}
}
EUVIMED